BETA DRUGS
Back to Balance Sheet
|
BETA DRUGS Last 5 Year Trade Payables History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Trade Payables | ₹71 Cr | ₹59 Cr | ₹40 Cr | ₹32 Cr | ₹20 Cr |
What is the latest Trade Payables ratio of BETA DRUGS ?
| Year | Trade Payables |
|---|---|
| Mar2025 | ₹71 Cr |
| Mar2024 | ₹59 Cr |
| Mar2023 | ₹40 Cr |
| Mar2022 | ₹32 Cr |
| Mar2021 | ₹20 Cr |
How is Trade Payables of BETA DRUGS Trending?
| Years | Trade Payables | % Change | |
|---|---|---|---|
| Mar2025 | ₹71 Cr | 20.20 | |
| Mar2024 | ₹59 Cr | 47.30 | |
| Mar2023 | ₹40 Cr | 25.94 | |
| Mar2022 | ₹32 Cr | 55.91 | |
| Mar2021 | ₹20 Cr | - | |
Compare Trade Payables of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹2,224.4 Cr | -1.8% | -6.2% | 14.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,562.0 Cr | -3.2% | -7.8% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,572.0 Cr | -3.3% | -0.2% | 63.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,871.0 Cr | -2.4% | -5% | 33.6% | Stock Analytics | |
| CIPLA | ₹107,770.0 Cr | -4% | -5.6% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,829.0 Cr | -1.2% | 4.1% | -4.2% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | -1.8% |
-6.2% |
14.4% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses